Discover oncology

Metformin's multiple effects in colorectal cancer and how it works with standard treatments

Updated

Abstract

Essence

Metformin may affect colorectal cancer progression and treatment resistance through multiple cancer-related pathways.

Evidence

This narrative review discusses metformin's effects on apoptosis, autophagy, , ABC transporters, , and possible synergy with chemotherapy and radiotherapy in CRC.

Caveat

The abstract presents mechanistic and therapeutic rationale rather than new clinical outcome data showing that metformin improves CRC treatment results.

Simplified

Key numbers

50
5-FU Clinical Trial Patients
Patients with refractory metastatic colorectal cancer in a phase 2 clinical trial.
41
Irinotecan Clinical Trial Patients
Patients with refractory colorectal cancer in a clinical trial evaluating metformin's effects.

Full Text

We can’t show the full text here under this license.

Funding

Competing interests

0 of 6
authors report competing interests
6 report none
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free